Musfaz83

Musfaz83 | Joined since 2020-02-23

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

619

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
619
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2020-07-03 14:56 | Report Abuse

da nk AGM saham kne cantik hihi

Stock

2020-07-02 10:36 | Report Abuse

laii

Stock

2020-07-02 08:56 | Report Abuse

solar related co jalan

Stock

2020-06-30 10:09 | Report Abuse

25sen resistance

Stock

2020-06-29 09:17 | Report Abuse

naik lebih 10sen jap lagi

Stock
Stock

2020-06-06 05:29 | Report Abuse

Telcos may consider M&A to ramp up scale, innovation, says Roland Berger

Telcos may consider M&A to ramp up scale, innovation, says Roland Berger

By Bernama | 2020-06-06 00:55:56
KUALA LUMPUR (June 5): Telecommunication service providers with access to capital will likely explore tactical opportunities post COVID-19, including mergers and acquisitions (M&A) to rapidly ramp up scale and innovation, foresees a global strategy consulting firm.

Roland Berger Southeast Asia co-managing partner Damien Dujacquier said the value of sectors such as communications and technology relative to the overall market has risen as resilience becomes evident amidst the crisis.

“We at Roland Berger start to recognise a growing theme around acquiring capabilities with a significant role in the post-COVID world, namely video conferencing solutions, virtual concerts and virtualised networks.

Stock

2020-06-01 21:04 | Report Abuse

Logic

Stock

2020-05-29 14:44 | Report Abuse

Tgt 14sen

Stock
Stock

2020-05-11 08:13 | Report Abuse

By Bernama | 2020-05-08 23:40:21
KUALA LUMPUR (May 8): The COVID-19 pandemic will accelerate the move by companies particularly micro, small and medium-sized enterprises (MSMEs) towards the digital economy, said Alibaba Group.

Stock

2020-04-30 14:26 | Report Abuse

High 30.5c

Stock

2020-04-14 10:23 | Report Abuse

Biohldg 11.5sen

PE 11x
Net asset 19c
www.bioa.com.my

The Group expects the operating environment to remain challenging for both local and
overseas markets, in line with the prevailing cautious consumer spending, with uncertainties
arising from geopolitical tensions and coronavirus (“Covid-19”) outbreak. Against this
backdrop, the Group remains focused on strengthening the manufacturing of health
supplement products and retail pharmacy businesses while keeping cost in check.
For the domestic manufacturing business, the Group continues its efforts to secure new
Original Design Manufacturing (“ODM”) customers, while servicing our existing ones. We
expect the local ODM market to pick up going into FY2020.
Nonetheless, in the short term, concerns still remain following the unexpected Covid-19
outbreak. We have since experienced a surge in sales at our Constant pharmacy outlets for
hygiene-related items such as surgical masks and sanitizers, as well as our immunity-related
health supplement products. However, the overall impact of the situation can only be
assessed in the coming months. We are monitoring the outbreak closely and are taking
proactive steps to manage any situation arising from it.
As for our export business, in view of the current developments and Covid-19 outbreak, the
Group expects export sales to pick up in the second half of the year. Specifically in China, the
Group continues to work closely with distributors and partners there. Progress in Indonesia,
on the other hand, had been muted in FY2019 due to slower-than-expected regulatory
approvals for the health supplement products. The Group foresees revenue from Indonesia
to pick up once more approvals are secured in FY2020.

Stock